Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice

Arihiko Kanehiro, Katsuyuki Takeda, Anthony Joetham, Adrian Tomkinson, Toshihide Ikemura, Charles G. Irvin, Erwin W. Gelfand

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The development of airway hyperresponsiveness (AHR) is correlated with the infiltration into the lungs of activated eosinophils and T lymphocytes. In large part, influx of eosinophils into the lung is dependent on very late activating antigen-4 (VLA-4) expression. However, the kinetics of eosinophil recruitment and the development of AHR are not fully delineated. Airway function was monitored by changes in lung resistance (RL) and dynamic compliance (Cdyn) to methacholine (MCh) inhalation after anti-VLA-4. After ovalbumin (OVA) sensitization and airway challenge of BALB/c mice, AHR increased as did the number of lung inflammatory cells. Administration of anti-VLA-4 to sensitized mice 2 h before the first (of three) OVA airway challenges significantly prevented changes in RL. Moreover, injection of the antibody from 2 h before the first challenge to 42 h after the last challenge significantly prevented the increases in RL, as well as eosinophil and lymphocyte numbers in the bronchoalveolar lavage fluid (BALF); interleukin-5 (IL-5) and leukotriene concentrations in BALF were also significantly inhibited. Interestingly, treatment with anti-VLA-4 only prevented changes in Cdyn and goblet cell hyperplasia when administered 2 h before the first challenge. These studies demonstrate that the timing of anti-VLA-4 administration can selectively affect pathologic processes that contribute to altered airway function in the central and peripheral airways after allergen challenge.

Original languageEnglish
Pages (from-to)1132-1139
Number of pages8
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume162
Issue number3 I
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Integrin alpha4beta1
Eosinophils
Lung
Ovalbumin
Bronchoalveolar Lavage Fluid
Goblet Cells
Methacholine Chloride
Leukotrienes
Interleukin-5
Lymphocyte Count
Pathologic Processes
Allergens
Inhalation
Compliance
Hyperplasia
T-Lymphocytes
Injections
Antibodies

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Kanehiro, A., Takeda, K., Joetham, A., Tomkinson, A., Ikemura, T., Irvin, C. G., & Gelfand, E. W. (2000). Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice. American Journal of Respiratory and Critical Care Medicine, 162(3 I), 1132-1139.

Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice. / Kanehiro, Arihiko; Takeda, Katsuyuki; Joetham, Anthony; Tomkinson, Adrian; Ikemura, Toshihide; Irvin, Charles G.; Gelfand, Erwin W.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 162, No. 3 I, 2000, p. 1132-1139.

Research output: Contribution to journalArticle

Kanehiro, A, Takeda, K, Joetham, A, Tomkinson, A, Ikemura, T, Irvin, CG & Gelfand, EW 2000, 'Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice', American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 3 I, pp. 1132-1139.
Kanehiro, Arihiko ; Takeda, Katsuyuki ; Joetham, Anthony ; Tomkinson, Adrian ; Ikemura, Toshihide ; Irvin, Charles G. ; Gelfand, Erwin W. / Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice. In: American Journal of Respiratory and Critical Care Medicine. 2000 ; Vol. 162, No. 3 I. pp. 1132-1139.
@article{29b1d008442a4175af653d806ccdbb54,
title = "Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice",
abstract = "The development of airway hyperresponsiveness (AHR) is correlated with the infiltration into the lungs of activated eosinophils and T lymphocytes. In large part, influx of eosinophils into the lung is dependent on very late activating antigen-4 (VLA-4) expression. However, the kinetics of eosinophil recruitment and the development of AHR are not fully delineated. Airway function was monitored by changes in lung resistance (RL) and dynamic compliance (Cdyn) to methacholine (MCh) inhalation after anti-VLA-4. After ovalbumin (OVA) sensitization and airway challenge of BALB/c mice, AHR increased as did the number of lung inflammatory cells. Administration of anti-VLA-4 to sensitized mice 2 h before the first (of three) OVA airway challenges significantly prevented changes in RL. Moreover, injection of the antibody from 2 h before the first challenge to 42 h after the last challenge significantly prevented the increases in RL, as well as eosinophil and lymphocyte numbers in the bronchoalveolar lavage fluid (BALF); interleukin-5 (IL-5) and leukotriene concentrations in BALF were also significantly inhibited. Interestingly, treatment with anti-VLA-4 only prevented changes in Cdyn and goblet cell hyperplasia when administered 2 h before the first challenge. These studies demonstrate that the timing of anti-VLA-4 administration can selectively affect pathologic processes that contribute to altered airway function in the central and peripheral airways after allergen challenge.",
author = "Arihiko Kanehiro and Katsuyuki Takeda and Anthony Joetham and Adrian Tomkinson and Toshihide Ikemura and Irvin, {Charles G.} and Gelfand, {Erwin W.}",
year = "2000",
language = "English",
volume = "162",
pages = "1132--1139",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3 I",

}

TY - JOUR

T1 - Timing of administration of anti-VLA-4 differentiates airway hyperresponsiveness in the central and peripheral airways in mice

AU - Kanehiro, Arihiko

AU - Takeda, Katsuyuki

AU - Joetham, Anthony

AU - Tomkinson, Adrian

AU - Ikemura, Toshihide

AU - Irvin, Charles G.

AU - Gelfand, Erwin W.

PY - 2000

Y1 - 2000

N2 - The development of airway hyperresponsiveness (AHR) is correlated with the infiltration into the lungs of activated eosinophils and T lymphocytes. In large part, influx of eosinophils into the lung is dependent on very late activating antigen-4 (VLA-4) expression. However, the kinetics of eosinophil recruitment and the development of AHR are not fully delineated. Airway function was monitored by changes in lung resistance (RL) and dynamic compliance (Cdyn) to methacholine (MCh) inhalation after anti-VLA-4. After ovalbumin (OVA) sensitization and airway challenge of BALB/c mice, AHR increased as did the number of lung inflammatory cells. Administration of anti-VLA-4 to sensitized mice 2 h before the first (of three) OVA airway challenges significantly prevented changes in RL. Moreover, injection of the antibody from 2 h before the first challenge to 42 h after the last challenge significantly prevented the increases in RL, as well as eosinophil and lymphocyte numbers in the bronchoalveolar lavage fluid (BALF); interleukin-5 (IL-5) and leukotriene concentrations in BALF were also significantly inhibited. Interestingly, treatment with anti-VLA-4 only prevented changes in Cdyn and goblet cell hyperplasia when administered 2 h before the first challenge. These studies demonstrate that the timing of anti-VLA-4 administration can selectively affect pathologic processes that contribute to altered airway function in the central and peripheral airways after allergen challenge.

AB - The development of airway hyperresponsiveness (AHR) is correlated with the infiltration into the lungs of activated eosinophils and T lymphocytes. In large part, influx of eosinophils into the lung is dependent on very late activating antigen-4 (VLA-4) expression. However, the kinetics of eosinophil recruitment and the development of AHR are not fully delineated. Airway function was monitored by changes in lung resistance (RL) and dynamic compliance (Cdyn) to methacholine (MCh) inhalation after anti-VLA-4. After ovalbumin (OVA) sensitization and airway challenge of BALB/c mice, AHR increased as did the number of lung inflammatory cells. Administration of anti-VLA-4 to sensitized mice 2 h before the first (of three) OVA airway challenges significantly prevented changes in RL. Moreover, injection of the antibody from 2 h before the first challenge to 42 h after the last challenge significantly prevented the increases in RL, as well as eosinophil and lymphocyte numbers in the bronchoalveolar lavage fluid (BALF); interleukin-5 (IL-5) and leukotriene concentrations in BALF were also significantly inhibited. Interestingly, treatment with anti-VLA-4 only prevented changes in Cdyn and goblet cell hyperplasia when administered 2 h before the first challenge. These studies demonstrate that the timing of anti-VLA-4 administration can selectively affect pathologic processes that contribute to altered airway function in the central and peripheral airways after allergen challenge.

UR - http://www.scopus.com/inward/record.url?scp=0033829669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033829669&partnerID=8YFLogxK

M3 - Article

C2 - 10988142

AN - SCOPUS:0033829669

VL - 162

SP - 1132

EP - 1139

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3 I

ER -